Inhibikase Therapeutics Inc (IKT) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
5.59%7.23 | 7.66 | 7.38 | 6.77 | 5.61 | |
| Selling, General, and Administrative | 5.59%7.23 | 7.66 | 7.38 | 6.77 | 5.61 |
| Research and Development | 11.99%15.00 | 13.39 | 10.84 | 6.36 | 7.65 |
| Costs And Expenses | 5.60%22.23 | 21.05 | 17.84 | 13.78 | 12.77 |
| Operating Income/Loss | 5.60%-22.23 | -21.05 | -17.84 | -13.78 | -12.77 |
| Net Interest Income/Expense | 20.69%1.76 | 1.46 | 1.46 | 1.04 | 0.84 |
4.47%-20.47 | -19.59 | -16.38 | -12.73 | -11.93 | |
| Attributable To Parent | 4.47%-20.47 | -19.59 | -16.38 | -12.73 | -11.93 |
| Basic Average Shares | 12.81%196.94 | 174.57 | 172.31 | - | 90.05 |
| Diluted Average Shares | 12.81%196.94 | 174.57 | 172.31 | - | 90.05 |
| Basic Earnings Per Share | 9.09%-0.10 | -0.11 | -0.10 | - | -0.13 |
| Diluted Earnings Per Share | 9.09%-0.10 | -0.11 | -0.10 | - | -0.13 |